PeterMazzoneMDMPH, FCCP

PubMed

• Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
  Mazzone, P. J., Gould, M. K., Arenberg, D. A., Chen, A. C., Choi, H. K., Detterbeck, F. C., Farjah, F., Fong, K. M., Iaccarino, J. M., Janes, S. M., Kanne, J. P., Kaze...> ;Journal of the American College of Radiology : JACR. 2020 Jun 3
• Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
  Mazzone, P. J., Gould, M. K., Arenberg, D. A., Chen, A. C., Choi, H. K., Detterbeck, F. C., Farjah, F., Fong, K. M., Iaccarino, J. M., Janes, S. M., Kanne, J. P., Kaze...> ;Chest. 2020 Apr 27
• The CHEST Editorial Team: Serving Our Contributors and Readers.
  Mazzone, P. J.> ;Chest. 2019 Jul 8
• Development of a risk prediction model to estimate the probability of malignancy in pulmonary nodules being considered for biopsy.
  Reid, M.,Choi, H. K.,Han, X.,Wang, X.,Mukhopadhyay, S.,Kou, L.,Ahmad, U.,Wang, X.,Mazzone, P. J.> ;Chest. 2019 Apr 04
• Principled Lung Cancer Screening Follows Screening Principles.
  Mazzone, P. J., Jett, J.> ;Chest. 2018 Dec 12
• Biomarkers in lung cancer screening: achievements, promises and challenges.
  Seijo, L. M.,Peled, N.,Ajona, D.,Boeri, M.,Field, J. K.,Sozzi, G.,Pio, R.,Zulueta, J. J.,Spira, A.,Massion, P. P.,Mazzone, P. J.,Montuenga, L. M.> ;J Thorac Oncol. 2018 Dec 12
• Response.
  Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Hoo, G. W., Detterbeck, F. C.> ;Chest. 2018 Oct 7
• Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
  Choi, H. K., Ghobrial, M., Mazzone, P. J.> ;Annals of the American Thoracic Society. 2018 Oct 3
• Response.
  Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Hoo, G. W., Detterbeck, F. C.> ;Chest. 2018 Sep 10
• Control of Confounding and Reporting of Results in Causal Inference Studies: Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.
  Lederer, D. J.,Bell, S. C.,Branson, R. D.,Chalmers, J. D.,Marshall, R.,Maslove, D. M.,Ost, D. E.,Punjabi, N. M.,Schatz, M.,Smyth, A. R.,Stewart, P. W.,Suissa, S.,Adjei...> ;Ann Am Thorac Soc. 2018 Sep 20
• Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
  Choi, H. K.,Ghobrial, M.,Mazzone, P. J.> ;Ann Am Thorac Soc. 2018 Jul 25
• Sampling Utility of the Convex Probe Endobronchial Ultrasound Visible Intrapulmonary Lesion.
  Almeida, F. A., Salam, S., Mehta, A. C., Yuhico, L., Sarda, Y., Choi, H., Cicenia, J. C., Gildea, T., Machuzak, M., Mazzone, P., Oliveira, E., Sethi, S., Wang, X., Rey...> ;Journal of bronchology & interventional pulmonology. 2018 Jun 15
• COUNTERPOINT: Should Lung Cancer Screening Be Expanded to Persons Who Don't Currently Meet Accepted Criteria Set Forth by the CHEST Guidelines on Lung Cancer Screening...
  Mazzone, P. J.> ;Chest. 2018 Jun 10
• Rebuttal From Dr Mazzone.
  Mazzone, P. J.> ;Chest. 2018 Jun 10
• Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
  Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., Leard, L. E., Lennes, ...> ;Journal of the National Comprehensive Cancer Network : JNCCN. 2018 Apr 11
• Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Class...
  Silvestri, G. A., Tanner, N. T., Kearney, P., Vachani, A., Massion, P. P., Porter, A., Springmeyer, S. C., Fang, K. C., Midthun, D. E., Mazzone, P. J.> ;Chest. 2018 Mar 3
• 2 citations
  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
  Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Hoo, G. W., Detterbeck, F. C.> ;Chest. 2018 Jan 29
• Electromagnetic Navigational Bronchoscopy versus CT-guided Percutaneous Sampling of Peripheral Indeterminate Pulmonary Nodules: A Cohort Study.
  Bhatt, K. M., Tandon, Y. K., Graham, R., Lau, C. T., Lempel, J. K., Azok, J. T., Mazzone, P. J., Schneider, E., Obuchowski, N. A., Bolen, M. A.> ;Radiology. 2017 Nov 21
• Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients.
  Banjara, M., Ghosh, C., Dadas, A., Mazzone, P. J., Janigro, D.> ;PloS one. 2017 Jul 27
• 7 citations
  Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
  Morgan, L., Choi, H., Reid, M., Khawaja, A., Mazzone, P. J.> ;Annals of the American Thoracic Society. 2017 Apr 20
• 7 citations
  Impact of a Lung Cancer Screening Counseling and Shared Decision-Making Visit.
  Mazzone, P. J., Tenenbaum, A., Seeley, M., Petersen, H., Lyon, C., Han, X., Wang, X.> ;Chest. 2016 Nov 7
• 1 citation
  Obstacles to and Solutions for a Successful Lung Cancer Screening Program.
  Mazzone, P. J.> ;Seminars in respiratory and critical care medicine. 2016 Oct 13
• 3 citations
  S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer.
  Choi, H., Puvenna, V., Brennan, C., Mahmoud, S. Y., Wang, X., Phillips, M. D., Janigro, D., Mazzone, P. J.> ;Translational lung cancer research. 2016 Sep 22
• Routine venous thromboembolism screening after pneumonectomy: The more you look, the more you see.
  Raja, S.,Idrees, J. J.,Blackstone, E. H.,He, J.,Badjatiya, A.,Mazzone, P.,Mason, D. P.,Rice, T. W.,Raymond, D. P.,Murthy, S. C.> ;J. Thorac. Cardiovasc. Surg.. 2016 Jun 02
• 2 citations
  Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.
  Mazzone, P. J., Wang, X., Lim, S., Choi, H., Jett, J. R., Vachani, A., Zhang, Q., Beukemann, M., Seeley, M., Martino, R., Rhodes, P. A.> ;BMC cancer. 2015 Dec 25
• Join now to see all